PRESS RELEASE published on 12/20/2023 at 12:45, 1 year 11 months ago MindBio Therapeutics CEO Provides End of Year Video Update on Phase 2 Clinical Trials
PRESS RELEASE published on 11/21/2023 at 14:42, 2 years ago MindBio Therapeutics Team Members Honoured with Industry Leading Awards
PRESS RELEASE published on 10/31/2023 at 07:30, 2 years 1 month ago MindBio Therapeutics CEO Presents World First Phase 2B Take-Home Microdosing Clinical Trial in Cancer Patients
PRESS RELEASE published on 10/29/2023 at 03:00, 2 years 1 month ago MindBio Therapeutics Begins Dosing MB22001 in World First Phase 2B Microdosing Clinical Trial In Advanced Stage Cancer Patients
PRESS RELEASE published on 10/26/2023 at 14:50, 2 years 1 month ago Mindbio Therapeutics Nominated for Company of the Year in Industry Awards
PRESS RELEASE published on 10/24/2023 at 13:25, 2 years 1 month ago MindBio Therapeutics CEO Provides Video Update on Phase 2a Depression Trial Using MB22001
PRESS RELEASE published on 10/05/2023 at 11:29, 2 years 2 months ago Tenth Patient With Depression Starts Dosing MB22001 in Take Home Microdosing Trials
PRESS RELEASE published on 09/14/2023 at 15:45, 2 years 2 months ago Mindbio Therapeutics CEO Provides Update on Depression Trial & Novel Discoveries in Psychedelics Research
PRESS RELEASE published on 09/05/2023 at 11:50, 2 years 3 months ago MindBio Therapeutics Announces Major Genetic Discovery in Microdosing Research
PRESS RELEASE published on 08/24/2023 at 08:30, 2 years 3 months ago Begins Dosing Mb22001 in Phase 2 Clinical Trial in World First Take-Home Microdosing Study in Patients with Depression
Published on 12/05/2025 at 02:35, 10 hours 7 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 11 hours 42 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 13 hours 37 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 13 hours 42 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 12:05, 36 minutes ago Cango Inc. Announces November 2025 Bitcoin Production and Mining Operations Update
Published on 12/05/2025 at 12:00, 41 minutes ago CGTN：Strengthening cultural ties: Peng Liyuan, Brigitte Macron visit Beijing People's Art Theatre
Published on 12/05/2025 at 12:00, 42 minutes ago Iute Group: Successful Issue of Additional EUR 2025/2030 Bonds – Circulating Volume Increased to EUR 160 Million
Published on 12/05/2025 at 11:14, 1 hour 27 minutes ago Halfords Group PLC: Director/PDMR Shareholding
Published on 12/05/2025 at 10:30, 2 hours 12 minutes ago Tradegate Exchange and Börse Berlin merge to form Tradegate BSX
Published on 12/05/2025 at 08:45, 3 hours 57 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 18 hours 42 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 18 hours 57 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 18 hours 57 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 5 hours ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
